Loading quotes...
Forecast
The analysts' average price target is €15.20 (+1,483.33%). The median is €15.20 (+1,483.33%).
| Buy |
Â
9 |
| Hold |
Â
4 |
| Sell |
Â
0 |
News Go to news feed
American Vanguard boosts margins in Q1 2026 after restructuring
American Vanguard beat expectations in Q1 2026 with net revenues of $123.6 million and raised adjusted EBITDA by 245% to $10.3 million. Gross margin improved by 500 basis points to 31%, driven by a stronger US business (+17%) and a more margin-accretive product mix, while international business temporarily declined by 7%. Net debt climbed to $195.7 million (Net Leverage 4.6x); the company refinanced its credit line into a multi-year loan structure and plans to reduce Net Leverage to 3.0x by 2028. As growth levers, American Vanguard is focusing on operational efficiency and an innovation pipeline with over 50 planned product launches and the goal of achieving roughly $100 million in additional annual revenue by 2030. » More on de.investing.com
American Vanguard underperforms despite operational turnaround
Riverwater Partners flagged American Vanguard as a quarterly performance detractor despite management-led improvements. Since a new CEO took over, inventory fell about 20% year‑over‑year, gross margin widened to 29% from 15%, and adjusted EBITDA rose to $8 million from $2 million. Riverwater says the company’s operating profile is materially stronger, though the stock has moved opposite to those improvements amid micro‑cap market inefficiencies. » More on finance.yahoo.com
American Vanguard appoints Mike DiPaola as CCO and relocates headquarters to Irvine
American Vanguard names Mike DiPaola chief commercial officer with a focus on business strategy and execution in North America; DiPaola has been with the company since February 2025 and has more than 25 years of experience in the agricultural sector. The company plans to move its headquarters from Newport Beach to Discovery Park in Irvine and complete the relocation by the end of Q2 2026. As part of an operational realignment, American Vanguard is closing non-core branches across its sites, while the stock has fallen sharply over the past three months and is down around 20% year-to-date. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 102.3m | 6.75% |
| Gross profit | 30.42m | 11.58% |
| Net profit | -8.65m | 1,100.38% |
| EBITDA | 3.49m | 52.87% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €27.17m |
Number of shares | 29.5m |
52-week high/low | €4.96 - €0.89 |
| Dividends | No |
Beta | 1.50 |
P/E ratio | -0.55 |
PEG ratio | -0.01 |
P/B ratio | 0.16 |
P/S ratio | 0.06 |
Company profile
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, soil health, plant nutrition, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. The company also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes chemicals for turf and ornamental markets. It distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. The company was incorporated in 1969 and is headquartered in Newport Beach, California.
| Name | American Vanguard Co. |
| CEO | Douglas A. Kaye |
| Headquarters | Newport Beach,
ca USA |
| Website | |
| Sector | Materials |
| Industry | Chemicals |
| IPO | 03/03/1987 |
| Employees | 739 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | AVD |
Frankfurt | AVJ.F |
DĂĽsseldorf | AVJ.DU |